| abstract |
The present invention relates to a crystalline solid form of a soluble guanylate cyclase (sGC) stimulant (Compound I). The invention also provides methods for preparing these solid forms. The present invention also relates to pharmaceutical formulations and dosage forms comprising these solid forms and their use, alone or in combination with one or more other agents, for the treatment and / or prevention of various diseases or conditions; such diseases or conditions benefit from sGC stimulation Or a disease or condition in which the concentration of nitric oxide (NO) and / or cyclic guanosine monophosphate (cGMP) is increased. |